Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04302961 · ClinicalTrials.gov registry record · Early Phase 1
Effects of Gait Retraining With Auditory Feedback
A Early Phase 1 study, sponsored by University of North Carolina, Charlotte.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 28
- Enrollment target
NCT04302961: Completed Early Phase 1 study, sponsored by University of North Carolina, Charlotte.
NCT04302961 is a Early Phase 1 study that has completed, run by University of North Carolina, Charlotte. The registered enrollment target is 28 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (47% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04302961, a Early Phase 1 study, has completed, sponsored by University of North Carolina, Charlotte.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 28 participants
- Enrollment target
Study Summary
There is evidence to support individuals with chronic ankle instability (CAI) have altered gait biomechanics which may lead to re-injury and poor patient outcomes. Currently, there are no interventions specifically targeting these abnormal gait biomechanics. Evidence supports the use of an external focus of attention feedback to promote motor learning and retention. The overall purpose of randomized clinical trial is to determine the effects of a 2-week (8 session) gait retraining protocol using an auditory external feedback instrument can (1) alter biomechanics during functional tasks (walking, step-down, lunge, lateral hops, and balance) (2) improve ankle cartilage measures and (3) improve patient-reported outcome measures.
Primary Outcome
Plantar pressure and center of pressure trajectory measured with an in-shoe plantar pressure system
Interventions
- OTHER Auditory Feedback
- OTHER No Feedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2020-10-05 |
| Est. Completion | 2021-06-30 |
| Phase | Early Phase 1 |
What the finished NCT04302961 record still lists
NCT04302961 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (47% lower).
The record links to 0 conditions, and to 2 interventions - of which Auditory Feedback is the first listed.
NCT04302961 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04302961 about?
NCT04302961 is a clinical study titled "Effects of Gait Retraining With Auditory Feedback". There is evidence to support individuals with chronic ankle instability (CAI) have altered gait biomechanics which may lead to re-injury and poor patient outcomes. Currently, there are no interventions specifically targeting these abnormal gait biomechanics. Evidence supports the use of an external ...
What is the current status of trial NCT04302961?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 28 participants. The study started on 2020-10-05. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT04302961?
The interventions under investigation include: Auditory Feedback (OTHER), No Feedback (OTHER).
Who is sponsoring clinical trial NCT04302961?
This trial is sponsored by University of North Carolina, Charlotte, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04302961's enrollment target sits among peer trials
28 938th of 2000 higher than 1,039 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI